For the year ending 2025-12-31, IR had -$292.4M decrease in cash & cash equivalents over the period. $1,220.1M in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Income from continuing operations | - | 846.3 | 785.1 | 593.3 |
| Net income | 588.8 | - | - | - |
| Amortization of intangible assets | 387.5 | 373 | 367.5 | 347.6 |
| Depreciation | 118.3 | 109 | 91.6 | 85.2 |
| Impairment of other intangible assets | - | 13.9 | - | 0 |
| Impairment of goodwill and other intangible assets | 273.4 | - | - | - |
| Non-cash restructuring charges | 0 | 1.6 | 2.7 | 6 |
| Stock-based compensation expense | 53 | 58.8 | 51.9 | 78.9 |
| Loss on equity method investments | -127.1 | -24 | -6 | 0.7 |
| Foreign currency transaction losses, net | -18.6 | -3.2 | -5.1 | 5.9 |
| Non-cash adjustments to carrying value of lifo inventories | 17.8 | 6.7 | 12 | 36.1 |
| Loss on extinguishment of debt | 0 | -3 | -13.5 | -1.1 |
| Loss on sale of asbestos-related assets and liabilities | 0 | -33.7 | - | - |
| Deferred income taxes | -79.4 | -33.1 | -76.9 | -85.8 |
| Other non-cash adjustments | -9.9 | -7.7 | -8.3 | -7 |
| Receivables | 59.1 | 45.1 | 48.6 | 195.2 |
| Inventories | 26.1 | -39.8 | -117.3 | 225.6 |
| Accounts payable | 78.7 | 13.3 | -23.9 | 120.4 |
| Accrued liabilities | -35.3 | -34.5 | 94.8 | 101.2 |
| Other assets and liabilities, net | 117.5 | 24.6 | 29 | -1.8 |
| Net cash provided by operating activities from continuing operations | - | 1,396.7 | 1,377.4 | 865.4 |
| Net cash provided by operating activities | 1,355.7 | - | - | - |
| Capital expenditures | 135.6 | 149.1 | 105.4 | 94.6 |
| Net cash paid in acquisitions | 525 | 2,958.7 | 963 | 246.8 |
| Disposals of property, plant and equipment | 0 | 6.1 | 7.6 | 0 |
| Other investing | 0 | 6 | -0.3 | -4.1 |
| Net cash used in investing activities from continuing operations | - | -3,107.7 | -1,060.5 | -337.3 |
| Net cash provided by (used in) investing activities | -660.6 | - | - | - |
| Principal payments on long-term debt | 0 | 1,242.7 | 1,518 | 655.6 |
| Proceeds from long-term debt | 0 | 3,296.9 | 1,490.4 | 0 |
| Purchases of treasury stock | 1,018 | 260.7 | 263 | 261.1 |
| Cash dividends on common stock | 31.8 | 32.3 | 32.4 | 32.4 |
| Proceeds from stock option exercises | 15.3 | 32.2 | 30.3 | 19.3 |
| Payments to settle cross-currency swaps | 0 | 19.9 | 0 | 13.4 |
| Payments of deferred and contingent acquisition consideration | 8 | 23.4 | 17.5 | 4.6 |
| Payments of debt issuance costs | 0 | 32.3 | 18.5 | 0 |
| Purchase of shares from noncontrolling interests | - | - | - | 0 |
| Proceeds from sale of noncontrolling interests | - | - | - | 0 |
| Other financing | -11.3 | -10.3 | -8.8 | -6.2 |
| Net cash provided by (used in) financing activities | -1,053.8 | 1,707.5 | -337.5 | -954 |
| Net cash used in operating activities | - | 0 | 0 | -5.1 |
| Net cash provided by investing activities | - | 0 | 0 | 4.4 |
| Net cash used in discontinued operations | - | 0 | 0 | -0.7 |
| Effect of exchange rate changes on cash and cash equivalents | 66.3 | -50.8 | 3.1 | -70 |
| Net decrease in cash and cash equivalents | -292.4 | -54.3 | -17.5 | -496.6 |
| Cash and cash equivalents at beginning of period | 1,541.2 | 1,595.5 | 1,613 | 2,109.6 |
| Cash and cash equivalents at end of period | 1,248.8 | 1,541.2 | 1,595.5 | 1,613 |
Ingersoll Rand Inc. (IR)
Ingersoll Rand Inc. (IR)